Image1_A Novel Small Molecular Inhibitor of DNMT1 Enhances the Antitumor Effect of Radiofrequency Ablation in Lung Squamous Cell Carcinoma Cells.JPEG
Radiofrequency ablation (RFA) is a relatively new and effective therapeutic strategy for treating lung squamous cell carcinomas (LSCCs). However, RFA is rarely used in the clinic for LSCC which still suffers from a lack of effective comprehensive treatment strategies. In the present work, we investigate iDNMT, a novel small molecular inhibitor of DNMT1 with a unique structure. In clinical LSCC specimens, endogenous DNMT1 was positively associated with methylation rates of miR-27-3p′s promoter. Moreover, endogenous DNMT1 was negatively correlated with miR-27-3p expression which targets PSEN-1, the catalytic subunit of γ-secretase, which mediates the cleavage and activation of the Notch pathway. We found that DNMT1 increased activation of the Notch pathway in clinical LSCC samples while downregulating miR-27-3p expression and hypermethylation of miR-27-3p′s promoter. In addition of inhibiting activation of the Notch pathway by repressing methylation of the miR-27-3p promoter, treatment of LSCC cells with iDNMT1 also enhanced the sensitivity of LSCC tumor tissues to RFA treatment. These data suggest that iDNMT-induced inhibition of DNMT-1 enhances miR-27-3p expression in LSCC to inhibit activation of the Notch pathway. Furthermore, the combination of iDNMT and RFA may be a promising therapeutic strategy for LSCC.
History
References
- https://doi.org//10.3389/fonc.2021.788084
- https://doi.org//10.1016/j.phrs.2017.07.021
- https://doi.org//10.1016/S0140-6736(20)32714-8
- https://doi.org//10.2217/pmt-2021-0068
- https://doi.org//10.1080/02656736.2021.1970826
- https://doi.org//10.3389/fonc.2020.567021
- https://doi.org//10.1016/j.phrs.2021.105818
- https://doi.org//10.1158/0008-5472.CAN-08-3669
- https://doi.org//10.3389/fonc.2020.578633
- https://doi.org//10.1186/s12885-015-1949-7
- https://doi.org//10.1016/j.phrs.2021.105648
- https://doi.org//10.3389/fonc.2021.787780
- https://doi.org//10.1002/hep.32177
- https://doi.org//10.1016/j.phrs.2020.105188
- https://doi.org//10.1016/S0140-6736(21)02098-5
- https://doi.org//10.1016/j.bbagen.2018.01.011
- https://doi.org//10.1016/j.phrs.2018.06.021
- https://doi.org//10.1002/ame2.12076
- https://doi.org//10.2147/DDDT.S249156
- https://doi.org//10.2147/OTT.S244474
- https://doi.org//10.1016/j.semcancer.2021.04.008
- https://doi.org//10.1111/acel.13526
- https://doi.org//10.3389/fcvm.2019.00113
- https://doi.org//10.1016/j.neo.2020.10.005
- https://doi.org//10.2174/0929867329666211228111036
- https://doi.org//10.7150/jca.49231
- https://doi.org//10.1016/j.jep.2021.114559
- https://doi.org//10.3389/fonc.2021.684070
- https://doi.org//10.2147/JHC.S268300
- https://doi.org//10.1016/j.canlet.2016.02.041
- https://doi.org//10.1016/j.phrs.2021.105686
- https://doi.org//10.1016/j.lfs.2020.119007
- https://doi.org//10.1016/j.bbagen.2016.04.007
- https://doi.org//10.1186/s13148-019-0719-9
- https://doi.org//10.1016/j.ejphar.2021.174214
- https://doi.org//10.14218/JCTH.2020.00125
- https://doi.org//10.1016/j.phrs.2021.105941
- https://doi.org//10.1074/jbc.M113.490482
- https://doi.org//10.1016/j.surg.2021.07.043
- https://doi.org//10.1039/d0fo02270e
- https://doi.org//10.1111/cpr.12480
- https://doi.org//10.1016/j.lfs.2020.117343
- https://doi.org//10.1016/j.phrs.2019.104406
- https://doi.org//10.1016/j.cellsig.2012.11.004
- https://doi.org//10.2147/OTT.S105745
- https://doi.org//10.1016/j.phrs.2020.105071
- https://doi.org//10.1016/j.jtho.2021.11.003
- https://doi.org//10.21037/tlcr-20-1185
- https://doi.org//10.1111/hepr.13633
- https://doi.org//10.7150/jca.60974
- https://doi.org//10.1080/10428194.2019.1627534
- https://doi.org//10.1016/j.phrs.2019.104609
- https://doi.org//10.1016/j.phrs.2021.105463
- https://doi.org//10.1016/j.phrs.2021.106037
- https://doi.org//10.1038/s41467-021-26823-6
- https://doi.org//10.1016/j.bbamcr.2021.119192
- https://doi.org//10.1007/s12032-021-01574-y
- https://doi.org//10.1038/s41419-020-02934-8
- https://doi.org//10.1038/s41419-021-04263-w
- https://doi.org//10.1002/ame2.12085
- https://doi.org//10.1016/S0140-6736(21)00312-3
- https://doi.org//10.1002/jcc.21334
- https://doi.org//10.1016/j.phrs.2020.105110
- https://doi.org//10.3389/fonc.2021.773644
- https://doi.org//10.1016/j.phrs.2021.105869
- https://doi.org//10.1016/j.lfs.2021.119521
- https://doi.org//10.1038/s41419-021-03836-z
- https://doi.org//10.1007/s13402-020-00526-4
- https://doi.org//10.1016/j.semcancer.2020.05.010
- https://doi.org//10.1016/j.metabol.2021.154909
- https://doi.org//10.2147/OTT.S165000
- https://doi.org//10.18632/oncotarget.24165
- https://doi.org//10.18632/oncotarget.20119
- https://doi.org//10.2174/1389450122666210120141546
- https://doi.org//10.1038/s41419-020-03053-0
- https://doi.org//10.1016/j.cellsig.2013.08.029
- https://doi.org//10.1016/j.apsb.2021.06.003
- https://doi.org//10.2147/OTT.S315832
- https://doi.org//10.1016/j.ejcb.2021.151181
- https://doi.org//10.1096/fj.202002319RRR
- https://doi.org//10.1177/09603271211038743
- https://doi.org//10.1007/s00432-019-02852-z
- https://doi.org//10.1016/j.biopha.2022.112616
- https://doi.org//10.1038/s41419-021-04160-2
- https://doi.org//10.1038/s41598-017-14897-6
- https://doi.org//10.1038/s41419-018-0804-6
- https://doi.org//10.3389/fonc.2021.694491
- https://doi.org//10.2147/OTT.S212596
- https://doi.org//10.4103/jcrt.JCRT_12_20
- https://doi.org//10.1016/j.phrs.2020.105392
- https://doi.org//10.3389/fonc.2021.796152
- https://doi.org//10.1016/j.ejphar.2021.174222